Blog
RSS FeedPosted by Michael Wonder on 05 Dec 2018
PHARMAC - 2018 in review (update)
6 December 2018 - Further analysis of the ten new patent protected medicines (i.e. new chemical entities) listed in the ...
Posted by Michael Wonder on 05 Dec 2018
NICE terminates two appraisals
5 December 2018 - NICE is unable to make a recommendation about the use of two medicines in the NHS because ...
Posted by Michael Wonder on 05 Dec 2018
NHS to save £1 billion on its medicines bill in 2019
5 December 2018 - The NHS is expected to save around £930 million on its medicines bill across the UK ...
Posted by Michael Wonder on 04 Dec 2018
Flexibility on cancer drugs approval will foster innovation
4 December 2018 - Between 2000 and 2016, no new drugs were approved for cancers of the brain, and there were ...
Posted by Michael Wonder on 04 Dec 2018
New cancer drugs taking longer to reach NHS patients
4 December 2018 - NHS patients are waiting longer for new cancer drugs because of delays in taking them through ...
Posted by Michael Wonder on 04 Dec 2018
Mulholland supports calls for PHARMAC Inquiry
4 December 2018 - Stage four breast cancer sufferer Wiki Mulholland is supporting calls for an Inquiry into PHARMAC. ...
Posted by Michael Wonder on 04 Dec 2018
NICE backs Cimzia for psoriasis, but rejects Ilumetri
4 December 2018 - Cost watchdog NICE has backed NHS funding for UCB’s Cimzia as a treatment for psoriasis, but ...
Posted by Michael Wonder on 04 Dec 2018
Enstilar is now covered by the Alberta Drug Benefit List for adults with psoriasis vulgaris
3 December 2018 - Leo Pharma Canada has announced that as of 1 December 2018, Enstilar has been added as ...
Posted by Michael Wonder on 04 Dec 2018
Medicines for severe asthma and growth hormone deficiency listed on the PBS
1 December 2018 - The Australian Government will list new medicines for severe asthma, and severe growth hormone deficiency on the ...
Posted by Michael Wonder on 03 Dec 2018
PHARMAC - 2018 in review
4 December 2018 - Yet another disappointing year in terms of patients in New Zealand being able to obtain subsidised ...
Posted by Michael Wonder on 03 Dec 2018
Canadian R&D-to-sales ratio for brand-name drug companies less than half of 10% commitment
3 December 2018 - USMCA concessions latest hit to Canadian prescription drug costs. ...
Posted by Michael Wonder on 03 Dec 2018
Canadians with rare lung disease are relieved to now have publicly funded access to potentially life-extending treatment
30 November 2018 - Uptravi now funded for the majority of Canadians with pulmonary arterial hypertension, but other treatments remain ...
Posted by Michael Wonder on 02 Dec 2018
Schedule of Pharmaceutical Benefits - 1 December 2018
1 December 2018 - The December 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Dec 2018
New PBS listing vital to Australians living with acute myeloid leukaemia
30 November 2018 - Leukaemia Foundation CEO Mr Bill Petch has today supported the Health Minister Mr Greg Hunt’s PBS ...
Posted by Michael Wonder on 30 Nov 2018
New Zealand Pharmaceutical Schedule - 1 December 2018 update
1 December 2018 - The December 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...